Géczi L - Search Results

1

[First Hungarian experience with pazopanib therapy for patients with metastatic renal cancer].

Maráz A, Bodrogi I, Csejtei A, Dank M, Géczi L, Küronya Z, Mangel L, Petrányi A, Szûcs M, Bodoky G. Maráz A, et al. Among authors: geczi l. Magy Onkol. 2013 Sep;57(3):173-6. Epub 2013 Aug 9. Magy Onkol. 2013. PMID: 24107823 Free article. Hungarian.

2

[Review of drugs used in the neutropenic period following cytostatic therapy and comparative study of doxycycline and ofloxacin in the treatment of patients with testicular cancer].

Baki M, Bodrogi I, Horti J, Géczi L. Baki M, et al. Among authors: geczi l. Orv Hetil. 1994 Dec 18;135(51):2815-9. Orv Hetil. 1994. PMID: 7838516 Review. Hungarian.

3

Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.

Bodrogi I, Baki M, Horti J, Géczi L, Liszka G, Ottó S, Hindy I, Eckhardt S, Sugár J. Bodrogi I, et al. Among authors: geczi l. Acta Med Hung. 1994;50(3-4):275-92. Acta Med Hung. 1994. PMID: 8587840 Clinical Trial.

4

Is p53 expression, detected by immunohistochemistry, an important parameter of response to treatment in testis cancer?

Eid H, Van der Looij M, Institoris E, Géczi L, Bodrogi I, Oláh E, Bak M. Eid H, et al. Among authors: geczi l. Anticancer Res. 1997 Jul-Aug;17(4A):2663-9. Anticancer Res. 1997. PMID: 9252698

5

Do metallothioneins affect the response to treatment in testis cancers?

Eid H, Géczi L, Bodrogi I, Institoris E, Bak M. Eid H, et al. Among authors: geczi l. J Cancer Res Clin Oncol. 1998 Jan;124(1):31-6. doi: 10.1007/s004320050130. J Cancer Res Clin Oncol. 1998. PMID: 9498832

6

Expression of bcl-2 in testicular carcinoma: correlation with tumor progression and MDR1/Pgp.

Eid H, Gulyás M, Géczi L, Bodrogi I, Institoris E, Bak M. Eid H, et al. Among authors: geczi l. Cancer. 1998 Jul 15;83(2):331-6. doi: 10.1002/(sici)1097-0142(19980715)83:2<331::aid-cncr17>3.3.co;2-3. Cancer. 1998. PMID: 9669816

7

Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteins.

Eid H, Géczi L, Mágori A, Bodrogi I, Institoris E, Bak M. Eid H, et al. Among authors: geczi l. Anticancer Res. 1998 Jul-Aug;18(4C):3059-64. Anticancer Res. 1998. PMID: 9713510

8

mdm-2 expression in human testicular germ-cell tumors and its clinical value.

Eid H, Institoris E, Géczi L, Bodrogi I, Bak M. Eid H, et al. Among authors: geczi l. Anticancer Res. 1999 Jul-Aug;19(4C):3485-90. Anticancer Res. 1999. PMID: 10629640

9

Three-year results of the first educational and early detection program for testicular cancer in Hungary.

Géczi L, Gomez F, Horváth Z, Bak M, Kisbenedek L, Bodrogi I. Géczi L, et al. Oncology. 2001;60(3):228-34. doi: 10.1159/000055323. Oncology. 2001. PMID: 11340374

10

[Bilateral germ cell testicular tumors].

Géczi L, Gomez F, Bak M, Bodrogi I. Géczi L, et al. Magy Onkol. 2001;45(5):417-423. Magy Onkol. 2001. PMID: 12050690 Free article. Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters